JP Morgan Initiates Coverage On Electra Therapeutics with Overweight Rating, Announces Price Target of $36
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsInitiationPrice Target
JP Morgan analyst Anupam Rama initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Overweight rating and announces Price Target of $36.
JP Morgan analyst Anupam Rama initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Overweight rating and announces Price Target of $36.